Evaluation of PET 18F-Fludarabine for the Initial Assessment and End-treatment of Symptomatic Multiple Myeloma Patients
Clinical trial NCT03832127 · RECRUITING
Trial details
- NCT number
- NCT03832127
- Sponsor
- Nantes University Hospital
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-09
- Primary completion
- 2024-09-09
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.